SIGNAL-DRIVEN SALES

Act on Executive-Hire Signals First

Track leadership moves and score urgency so you reach new decision-makers during their evaluation window.

10–25 decision-maker leads daily • First-90-days targeting • Intent scoring

Every plan includes:

✓Signal-Driven Leads Based on YOUR ICP

✓Role-aware buyer intent scoring

✓Direct outreach workflows

INDUSTRY FIRST

Sfa Therapeutics Appoints James Kirwin As Chief Operating Officer

Jul 16, 2024•about 1 year ago

Position

Chief Operating Officer

Company

SFA Therapeutics

James Kirwin

JenkintownBiopharmaTherapeuticsPharmaceuticalBiotechnology

Description

SFA Therapeutics, Inc. announced the appointment of James Kirwin, MBA, as Chief Operating Officer

Company Information

Company

SFA Therapeutics

Location

Jenkintown, Pennsylvania, United States

About

SFA Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for the treatment of inflammatory diseases. Based on breakthrough research licensed from Temple University, SFA Therapeutics' platform has the potential to develop safer and more efficacious treatments for a number of chronic inflammatory diseases by uniquely tailoring the effects of patented formulations with target-specific adjuvants.

FundzWatch™ Score

Medium Activity

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months